stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Dow:  
Nasdaq:  
S&P 500:  
Apnimed, Inc. Common StockAPMD
$16.320.49%-0.08

Apnimed, Inc. Common Stock (APMD)

Date: 2026-11-02 16:00O: 16.47H: 16.79L: 16.12C: 16.32Vol: 22.22k

Apnimed, Inc. Common Stock Stock (APMD) Forecast

The Apnimed, Inc. Common Stock (APMD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $20.36, representing a +24.75% increase from the current price of $16.32. The highest analyst price target is $23.10, and the lowest is $17.62.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month APMD Price Target
Average 11.70 (-28.29% Upside)

Is Apnimed, Inc. Common Stock (APMD) A Buy Now?

Oscillators
NameValueAction
RSI(14)35.09Neutral
STOCH(9,6)48.16Neutral
STOCHRSI(14)21.60Neutral
MACD(12,26)-1.42Buy
ADX(14)27.53Sell
William %R-94.61Buy
CCI(14)-94.24Neutral
Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
18.26
Sell
17.85
Sell
MA20
18.11
Sell
18.81
Sell
MA50
22.70
Sell
22.19
Sell
MA100
15.85
Buy
0.00
Buy
MA200
7.92
Buy
0.00
Buy
Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell

According to our latest analysis, APMD could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 7 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on APMD, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 35.09 indicates that APMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 48.16 indicates that APMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 21.60 indicates that APMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 27.53 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of -94.24 indicates that APMD is still oversold but not to an extreme extent.

Long-term APMD price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Apnimed, Inc. Common Stock financial reports and earnings history, Apnimed, Inc. Common Stock (APMD) stock could reach $91.25 by 2030, $375.05 by 2040 and $650.25 by 2050. See the projected annual prices until 2050 of the Apnimed, Inc. Common Stock stock below:

  • Apnimed, Inc. Common Stock (APMD) is expected to reach an average price of $161.35 in 2035, with a high prediction of $228.85 and a low estimate of $141.16. This indicates an +888.68% change from the last recorded price of $16.32.
  • Apnimed, Inc. Common Stock (APMD) stock is projected to chart a bullish course in 2040, with an average price target of $350.10, representing an +2,045% change from its current level. The forecast ranges from a conservative $234.38 to a sky-high $375.05.
  • Our analysts predict Apnimed, Inc. Common Stock (APMD) to change +2,559% by 2045, soaring from $333.43 to an average price of $434.03, potentially reaching $512.65. While $333.43 is the low estimate, the potential upside is significant.
  • Apnimed, Inc. Common Stock (APMD) stock is expected to climb by 2050, reaching an average of $485.59, a +2,875% change from its current level. However, a wide range of estimates exists, with high and low targets of $650.25 and $426.65, respectively, highlighting the market's uncertainty.

Apnimed, Inc. Common Stock Stock (APMD) Year by Year Forecast

Apnimed, Inc. Common Stock Stock (APMD) Price Forecast for 2026

The predicted value for Apnimed, Inc. Common Stock (APMD) in 2026 is set at an average of $22.21. Estimates vary from a peak of $35.29 to a trough of $7.52, indicating an +36.12% surge from the present price of $16.32.

MonthAverageLowHighChange from today's price
December, 2026$21.88$17.62$23.10+34.06%

Apnimed, Inc. Common Stock Stock (APMD) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Apnimed, Inc. Common Stock (APMD) is $5.97, with a high forecast of $21.96 and a low forecast of $0.3076. This indicates an -63.43% decrease from the last price of $16.32.

MonthAverageLowHighChange from today's price
January, 2027$12.14$10.99$21.96-25.62%
February, 2027$7.80$1.08$14.00-52.21%
March, 2027$10.90$5.52$19.20-33.22%
April, 2027$7.22$6.63$15.98-55.77%
May, 2027$6.97$4.41$11.37-57.31%
June, 2027$7.06$2.06$8.40-56.74%
July, 2027$4.98$1.75$11.15-69.50%
August, 2027$1.81$0.3076$8.86-88.90%
September, 2027$1.08$1.32$2.97-93.39%
October, 2027$4.15$4.54$5.25-74.56%
November, 2027$0.5168$3.04$1.74-96.83%
December, 2027$7.00$5.16$3.41-57.08%

Apnimed, Inc. Common Stock Stock (APMD) Price Forecast for 2028

In 2028, Apnimed, Inc. Common Stock (APMD) is projected to reach an average price of $20.39, with a high projection of $39.65 and a low estimate of $7.15. This indicates an +24.93% rise from the last price of $16.32.

MonthAverageLowHighChange from today's price
January, 2028$15.08$7.15$13.85-7.63%
February, 2028$12.13$12.59$8.31-25.69%
March, 2028$13.59$10.34$8.62-16.73%
April, 2028$13.22$11.73$10.98-18.99%
May, 2028$17.63$12.97$22.45+8.03%
June, 2028$17.49$19.83$16.11+7.19%
July, 2028$17.89$17.65$16.01+9.60%
August, 2028$18.56$18.80$17.18+13.72%
September, 2028$28.29$28.68$31.05+73.33%
October, 2028$20.85$24.80$23.66+27.73%
November, 2028$26.15$24.86$22.76+60.22%
December, 2028$43.80$24.63$39.65+168.38%

Apnimed, Inc. Common Stock Stock (APMD) Price Forecast for 2029

The 2029 price forecast for Apnimed, Inc. Common Stock Stock (APMD) is $44.24 on average, with a high prediction of $65.45 and a low estimate of $30.45. This represents an +171.07% increase from the previous price of $16.32.

MonthAverageLowHighChange from today's price
January, 2029$35.15$35.80$38.43+115.40%
February, 2029$34.40$31.92$31.09+110.77%
March, 2029$31.81$31.43$29.57+94.92%
April, 2029$42.32$30.45$48.25+159.32%
May, 2029$39.97$42.31$39.01+144.89%
June, 2029$38.85$39.04$36.26+138.05%
July, 2029$36.04$36.28$35.77+120.82%
August, 2029$52.42$52.81$56.85+221.22%
September, 2029$46.83$46.87$46.69+186.93%
October, 2029$45.29$44.56$43.01+177.52%
November, 2029$69.60$42.10$65.45+326.47%
December, 2029$58.18$58.83$63.67+256.50%

Apnimed, Inc. Common Stock Stock (APMD) Price Forecast for 2030

Apnimed, Inc. Common Stock Stock (APMD) is expected to reach an average price of $67.98 in 2030, with a high forecast of $91.25 and a low forecast of $47.93. This signifies an +316.54% surge from the last price of $16.32.

MonthAverageLowHighChange from today's price
January, 2030$55.20$53.28$53.57+238.27%
February, 2030$50.40$51.13$49.76+208.82%
March, 2030$73.98$47.93$74.05+353.32%
April, 2030$62.44$64.78$65.67+282.58%
May, 2030$59.10$60.40$58.02+262.14%
June, 2030$53.15$55.71$54.46+225.65%
July, 2030$76.56$53.76$82.65+369.11%
August, 2030$68.74$68.79$69.82+321.23%
September, 2030$64.44$64.26$63.26+294.83%
October, 2030$95.40$59.58$91.25+484.56%
November, 2030$80.34$84.72$88.92+392.25%
December, 2030$76.01$74.64$77.39+365.76%

Similar to APMD